Managing Migraines: A Comparative Look at Therapeutic Approaches

New emerging research from Nojek et al. (2024) presents a broad review of therapeutic approaches to migraine, reaffirming a truth well-known to clinicians and patients alike: no single method fits all. Migraine, a debilitating neurological condition marked by episodic or chronic headaches—often with nausea, light sensitivity, and fatigue—affects millions worldwide. For many, it becomes a lifelong burden that disrupts work, family life, and emotional wellbeing.

The study compares traditional pharmacological treatments (like triptans and beta-blockers) with non-pharmacological strategies such as biofeedback, acupuncture, and cognitive-behavioral therapy (CBT). It also addresses newer developments including neuromodulation techniques and botulinum toxin injections for chronic cases.

What’s particularly notable in this analysis is the space given to non-drug therapies like biofeedback, which aim not just to suppress symptoms but to empower patients through self-regulation. By teaching individuals to control physiological responses—like muscle tension or heart rate variability—biofeedback targets some of the root mechanisms behind migraines, including stress-related autonomic dysregulation.

Methods

Pharmacological Therapies

Acute Treatments

• Triptans and NSAIDs are often first-line choices for interrupting a migraine attack. They act quickly, but may trigger side effects like nausea or vasoconstriction, making them unsuitable for some patients.

Preventive Treatments

• Beta-blockers and antiepileptic drugs are commonly used to reduce the frequency of attacks. While effective, they can induce fatigue, cognitive dulling, or mood changes.

Non-Pharmacological Therapies

Biofeedback

• Patients are trained to consciously adjust physiological parameters, particularly muscle tension and autonomic balance. This typically involves EMG (for tension-type migraines), HRV training, or thermal biofeedback.

Acupuncture

• A well-tolerated intervention shown to reduce migraine frequency and intensity. It is particularly valuable for patients who prefer minimal pharmaceutical input.

Lifestyle and CBT

• Sleep hygiene, regular exercise, stress management, and cognitive restructuring are increasingly recognized as essential parts of migraine care, especially in chronic cases.

Innovative Therapies

Neuromodulation

• Non-invasive techniques like transcranial magnetic stimulation (TMS) and supraorbital nerve stimulation (SNS) aim to interrupt pain signals before they fully develop.

Botulinum Toxin Injections

• Approved for chronic migraine, these involve injections at specific cranial and neck locations every 12 weeks. Results are promising, especially in patients with high attack frequency.

Results

The study presents a balanced view of current therapeutic options:

• Triptans offer fast relief but can provoke side effects and rebound headaches.

• Beta-blockers and antiepileptics provide a solid preventative foundation but are not without cognitive and fatigue-related drawbacks.

• Biofeedback and acupuncture show strong outcomes in migraine frequency reduction with negligible side effects.

• CBT and lifestyle modifications improve patient engagement and stress resilience—important migraine triggers.

• Neuromodulation and botulinum toxin are effective but costly and less widely available, reserved for complex cases.

Across all modalities, the importance of personalization is emphasized. No method stands as a universal cure, but a tailored approach can offer significant relief.

Discussion

One key insight from the review is the clear need for integrated, multimodal migraine care. Pharmacological treatments remain essential, particularly for acute management, but they rarely address the broader biopsychosocial factors involved in chronic migraine. This is where biofeedback, neurofeedback, and lifestyle-based interventions become vital.

Biofeedback offers a way to engage patients actively in their own care. Whether through thermal feedback to train vasodilation, EMG biofeedback to reduce scalp and neck tension, or HRV biofeedback for autonomic balance, these techniques teach people to “see” and alter the physiological patterns that drive pain and reactivity.

When combined with CBT, which targets the cognitive and emotional contributors to stress and somatization, biofeedback becomes even more powerful. The two modalities reinforce each other: one works from the bottom-up (body to brain), the other top-down (brain to body).

Innovations like neuromodulation and botulinum injections are exciting, especially for drug-resistant cases. However, they require specialized equipment, are not accessible to all, and do not promote self-agency in the same way that self-regulation training does.

Brendan’s Perspective

This review highlights what many of us in clinical practice already observe: no single intervention can fully address migraines. They are complex, multi-systemic phenomena with neurological, vascular, muscular, hormonal, and psychological components. That’s why biofeedback and neurofeedback deserve a central place in treatment plans—not as alternatives to medicine, but as bridges between medical and self-regulatory care.

In neurofeedback, we often work with protocols aimed at calming cortical hyperexcitability and enhancing brain stability. For migraine, that means training to increase posterior alpha (8–12 Hz), typically at Pz or Oz, to promote a state of visual and sensory calm. For clients with comorbid anxiety or sleep disturbances, we may train SMR (12–15 Hz) at Cz or C4, supporting sensorimotor stability and improved sleep architecture.

In practice, the most effective protocols are often multi-modal. For example:

• EMG biofeedback (on frontalis or trapezius) + alpha uptraining can be used for patients with strong muscle tension components and photophobia.

• HRV biofeedback + SMR training is particularly helpful in stress-triggered migraine patterns, enhancing both autonomic and cortical control.

• Alpha-theta neurofeedback can help with clients who experience migraines related to unresolved trauma or emotional suppression, fostering deeper emotional processing and relaxation.

We must also acknowledge the limitations of these techniques when used in isolation. No amount of alpha training will overcome a patient’s three-hour sleep schedule or daily caffeine overload. A truly effective migraine protocol requires:

• Rigorous intake and tracking of lifestyle factors

• Continuous assessment of bio/neurofeedback response (e.g., using symptom logs or qEEG if available)

• Patient education to help them become experts in their own triggers and responses

Where possible, I recommend integrating neuromodulation (e.g., tDCS or CES) into home-based training plans. This gives patients access to calming input during vulnerable periods without full clinical supervision.

Ultimately, empowerment is the goal. Whether through breathing regulation, muscle control, or real-time feedback on cortical rhythms, migraine sufferers benefit most when they are given tools, not just treatments.

Conclusion

The treatment of migraines demands more than a pill—it requires a personalized, multimodal approach that addresses both the biology of pain and the behavior of the person experiencing it. By combining pharmacology, biofeedback, neurofeedback, and innovative therapies, we can give patients a broader, more hopeful path forward.

This integrative care model doesn’t just suppress symptoms—it builds resilience, encourages self-awareness, and promotes long-term well-being.

Reference

Nojek, P., Pawlik, W., Zimonczyk, M., Zawoł, M., Błaszczyński, G., & Nowotarska, A. (2024). A review of migraine treatment methods: A comparative analysis of therapeutic approaches. Journal of Education, Health and Sport, 70. https://dx.doi.org/10.12775/JEHS.2024.70.55858